Clearmind Medicine Inc.

NASDAQ: CMND · Real-Time Price · USD
1.03
0.01 (0.98%)
At close: Aug 15, 2025, 3:59 PM
1.03
0.00%
After-hours: Aug 15, 2025, 05:44 PM EDT

Clearmind Medicine Income Statement

Financials in USD. Fiscal year is November - October.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Oct 31, 2024 Oct 31, 2023 Oct 31, 2022 Oct 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
26.7K 56.34K 113.38K 2.57K
Gross Profit
-26.7K -56.34K -113.38K -2.57K
Operating Income
-6.3M -8.74M -8.53M -3.45M
Interest Income
271.22K 57.97K n/a n/a
Pretax Income
-4.88M -11.93M -9.37M -3.9M
Net Income
-5.25M -11.96M -9.41M -4.12M
Selling & General & Admin
4.35M 6.6M 5.43M 3.03M
Research & Development
1.38M 2.14M 2.98M 646.49K
Other Expenses
n/a n/a 113.38K n/a
Operating Expenses
5.72M 8.74M 8.53M 3.68M
Interest Expense
36.16K n/a 19.68K n/a
Selling & Marketing Expenses
1.09M n/a n/a n/a
Cost & Expenses
2.57M 8.74M 8.53M 3.68M
Income Tax Expense
377.97K 24.09K 40.75K 223.22K
Shares Outstanding (Basic)
4.27M 2.02M 433.34K 309.11K
Shares Outstanding (Diluted)
4.27M 2.02M 433.34K 309.11K
EPS (Basic)
-1.7 -42.58 -168.61 -95.67
EPS (Diluted)
-1.7 -42.58 -168.61 -95.67
EBITDA
-5.85M -8.71M -8.49M -3.67M
EBIT
n/a -8.74M -8.52M -3.69M
Depreciation & Amortization
51.07K 30.69K 113.38K 2.57K